PURPOSE: To develop media simulating human colonic fluids (HCFs), to evaluate their use in predicting intracolonic solubility of ketoconazole, danazol and felodipine and to compare solubilities in HCFs with previously determined solubilities in gastric (HGFs) and small intestinal (HIFs) fluids. METHODS: Fasted state simulated colonic fluid (FaSSCoF) and fed state simulated colonic fluid (FeSSCoF) were designed to reflect fluids previously collected from the ascending colon in healthy adults. Solubilities of the three model compounds were determined in HCFs, simulated HCFs, and plain buffers. RESULTS: For ketoconazole, solubilities in FaSSCoF and FeSSCoF were closer than those in the corresponding plain buffers to the solubility in HCFs. For danazol and felodipine, solubilities in FaSSCoF and FeSSCoF predicted solubilities in HCFs. In the fasted state, solubilities of danazol and felodipine in HCFs were higher than or similar to in HGFs or HIFs, while the ketoconazole solubility was lower. In the fed state, solubilities of all three model compounds in HCFs were lower than in HGFs or HIFs. CONCLUSIONS: FaSSCoF and FeSSCoF more closely predict solubility of poorly soluble compounds in HCFs than plain buffers. In most cases, solubility in HCFs differs from those in HGFs and HIFs.
PURPOSE: To develop media simulating human colonic fluids (HCFs), to evaluate their use in predicting intracolonic solubility of ketoconazole, danazol and felodipine and to compare solubilities in HCFs with previously determined solubilities in gastric (HGFs) and small intestinal (HIFs) fluids. METHODS: Fasted state simulated colonic fluid (FaSSCoF) and fed state simulated colonic fluid (FeSSCoF) were designed to reflect fluids previously collected from the ascending colon in healthy adults. Solubilities of the three model compounds were determined in HCFs, simulated HCFs, and plain buffers. RESULTS: For ketoconazole, solubilities in FaSSCoF and FeSSCoF were closer than those in the corresponding plain buffers to the solubility in HCFs. For danazol and felodipine, solubilities in FaSSCoF and FeSSCoF predicted solubilities in HCFs. In the fasted state, solubilities of danazol and felodipine in HCFs were higher than or similar to in HGFs or HIFs, while the ketoconazole solubility was lower. In the fed state, solubilities of all three model compounds in HCFs were lower than in HGFs or HIFs. CONCLUSIONS:FaSSCoF and FeSSCoF more closely predict solubility of poorly soluble compounds in HCFs than plain buffers. In most cases, solubility in HCFs differs from those in HGFs and HIFs.
Authors: Annette Scholz; Bertil Abrahamsson; Steffen M Diebold; Edmund Kostewicz; Britta I Polentarutti; Anna-Lena Ungell; Jennifer B Dressman Journal: Pharm Res Date: 2002-01 Impact factor: 4.200
Authors: Sarah Clarysse; Dimitrios Psachoulias; Joachim Brouwers; Jan Tack; Pieter Annaert; Guus Duchateau; Christos Reppas; Patrick Augustijns Journal: Pharm Res Date: 2009-03-07 Impact factor: 4.200
Authors: Prabhat Bhusal; Jamie Lee Rahiri; Bruce Sua; Jessica E McDonald; Mahima Bansal; Sara Hanning; Manisha Sharma; Kaushik Chandramouli; Jeff Harrison; Georgina Procter; Gavin Andrews; David S Jones; Andrew G Hill; Darren Svirskis Journal: Drug Deliv Transl Res Date: 2018-06 Impact factor: 4.617
Authors: Rebecca Nofsinger; Sophie-Dorothee Clas; Rosa I Sanchez; Abbas Walji; Kimberly Manser; Becky Nissley; Jaume Balsells; Amrithraj Nair; Qun Dang; David Jonathan Bennett; Michael Hafey; Junying Wang; John Higgins; Allen Templeton; Paul Coleman; Jay Grobler; Ronald Smith; Yunhui Wu Journal: Pharmaceuticals (Basel) Date: 2014-02-24
Authors: Mauricio A García; Felipe Varum; Jozef Al-Gousous; Michael Hofmann; Susanne Page; Peter Langguth Journal: Pharmaceutics Date: 2022-01-26 Impact factor: 6.321
Authors: Ilia Gelfat; Yousuf Aqeel; Jacqueline M Tremblay; Justyna J Jaskiewicz; Anishma Shrestha; James N Lee; Shenglan Hu; Xi Qian; Loranne Magoun; Abhineet Sheoran; Daniela Bedenice; Colter Giem; Avinash Manjula-Basavanna; Amanda R Pulsifer; Hann X Tu; Xiaoli Li; Marilyn L Minus; Marcia S Osburne; Saul Tzipori; Charles B Shoemaker; John M Leong; Neel S Joshi Journal: PLoS Pathog Date: 2022-09-15 Impact factor: 7.464